CCM
TECH icon

Coe Capital Management’s Bio-Techne TECH Stock Holding History

Coe Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,000
Closed -$564K – 251
2016
Q2 		$564K Buy
+20,000
New +$514K 0.19% 145

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Coe Capital Management's TECH Position: Q3 2016 in Review

Coe Capital Management sold out of Bio-Techne (TECH) in Q3 2016, closing a stake of 20,000 shares — an estimated $564K sold.

Coe Capital Management first reported a position in TECH in Q2 2016 and held it in 1 quarter. The position peaked at $564K in Q2 2016. 293 funds tracked by Wall St. Rank hold TECH as of Q3 2016.

  • Coe Capital Management reported no remaining Bio-Techne position as of Q3 2016 after selling out during the quarter.
  • Coe Capital Management sold 20,000 Bio-Techne shares in Q3 2016, an estimated $564K.
  • Coe Capital Management first reported a position in Bio-Techne in Q2 2016 and held it in 1 quarter.
  • Coe Capital Management's Bio-Techne position peaked at $564K in Q2 2016.
  • 293 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2016.

Based on Coe Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.